BDBM484061 (2S)-1-(3-(1- fluoroethylsulfonyl) phenoxy)-3-((R)-8- (quinolin-6-ylsulfonyl)- 1-oxa-8- azaspiro[4.5]decan-3- ylamino)propan-2-ol::US10927123, Compound 234

SMILES CC(F)S(=O)(=O)c1cccc(OC[C@@H](O)CN[C@H]2COC3(C2)CCN(CC3)S(=O)(=O)c2ccc3ncccc3c2)c1

InChI Key InChIKey=SHAYHNRTJQKVNJ-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 484061   

TargetBeta-3 adrenergic receptor(Human)
Arena Pharmaceuticals

US Patent
LigandPNGBDBM484061((2S)-1-(3-(1- fluoroethylsulfonyl) phenoxy)-3-((R)...)
Affinity DataIC50: 1.02E+4nMAssay Description:Compounds were dissolved and serially diluted (5-fold) in DMSO to generate a 10-point dose response stock. The stock was then diluted 100-fold in ass...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/6/2021
Entry Details
Go to US Patent